» Articles » PMID: 18799722

CX3CL1/fractalkine is Released from Apoptotic Lymphocytes to Stimulate Macrophage Chemotaxis

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2008 Sep 19
PMID 18799722
Citations 226
Authors
Affiliations
Soon will be listed here.
Abstract

Cells undergoing apoptosis are efficiently located and engulfed by phagocytes. The mechanisms by which macrophages, the professional scavenging phagocytes of apoptotic cells, are attracted to sites of apoptosis are poorly defined. Here we show that CX3CL1/fractalkine, a chemokine and intercellular adhesion molecule, is released rapidly from apoptotic lymphocytes, via caspase- and Bcl-2-regulated mechanisms, to attract macrophages. Effective chemotaxis of macrophages to apoptotic lymphocytes is dependent on macrophage fractalkine receptor, CX3CR1. CX3CR1 deficiency caused diminished recruitment of macrophages to germinal centers of lymphoid follicles, sites of high-rate B-cell apoptosis. These results provide the first demonstration of chemokine/chemokine-receptor activity in the navigation of macrophages toward apoptotic cells and identify a mechanism by which macrophage infiltration of tissues containing apoptotic lymphocytes is achieved.

Citing Articles

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.

Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y Signal Transduct Target Ther. 2025; 10(1):93.

PMID: 40055311 PMC: 11889221. DOI: 10.1038/s41392-025-02124-y.


The role of efferocytosis in inflammatory bowel disease.

Liu Y, Li Z, Han Y, Wang Q Front Immunol. 2025; 16:1524058.

PMID: 40040696 PMC: 11876057. DOI: 10.3389/fimmu.2025.1524058.


Efferocytosis and inflammation: a bibliometric and systematic analysis.

Cao X, Li F, Xie X, Ling G, Tang X, He W Front Med (Lausanne). 2025; 12:1498503.

PMID: 39995691 PMC: 11847848. DOI: 10.3389/fmed.2025.1498503.


Dendritic cell maturation in cancer.

Moon C, Belabed M, Park M, Mattiuz R, Puleston D, Merad M Nat Rev Cancer. 2025; .

PMID: 39920276 DOI: 10.1038/s41568-024-00787-3.


Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights.

Hoseinzadeh A, Esmaeili S, Sahebi R, Melak A, Mahmoudi M, Hasannia M Stem Cell Res Ther. 2025; 16(1):33.

PMID: 39901306 PMC: 11792531. DOI: 10.1186/s13287-025-04158-z.